RNASE2 and hepatocellular carcinoma: Results indicated that the 3-marker panel comprising RNASE2, TNF-α, and MAP3K7, which showed the best performance in detecting HCC from healthy controls, also exhibited acceptable performance in distinguishing HCC from CHB patients with an accuracy of 0.907 and AUC of 0.92 (Supplementary Table 5).